Options
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) option implied volatility low into 2021 analyst day
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) option implied volatility at low end of range
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) option implied volatility low
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) calls active into President Trump State of Union Address
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) volatility flat into President Trump speech to lower drug prices
-
-
-
-
-
-
-
Human Genome (HGSI) March volatility elevated at 136 into FDA approval of BENLYSTA
-
-
-
-
76,614 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All